Benicar (olmesartan), a new angiotensin receptor blocker for hypertension
June 2002
Reps will soon be promoting Benicar (olmesartan), a new angiotensin receptor blocker for hypertension.
It will be the seventh one on the market...after Cozaar (losartan), Diovan (valsartan), Avapro (irbesartan), Atacand (candesartan), Micardis (telmisartan), and Teveten (eprosartan).
Benicar has a long half-life...but don't get too excited. It's pretty much a "me-too."
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote